{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-25-000041","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.588925+00:00","generated_at":"2026-05-17T18:43:36.098918+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"US Physical Therapy Q2 net income $12.4M; raises FY Adj EBITDA guidance to $93M-$97M","bullets":["Q2 total revenue from PT ops $168.3M (+17.3%), IIP revenue $29.1M (+22.6%); record patient visits 1.56M (+16.7%).","Net income attributable to USPH $12.4M ($0.58 EPS) vs $7.5M ($0.47); Adjusted EBITDA $26.9M (+21.4%).","Quarterly dividend $0.45/share payable Sept 12; new $25M share repurchase program authorized through Dec 2026.","Acquired 80% of a home-care practice ($2.1M annual revenue) and 60% of a 3-clinic practice ($5.3M annual revenue)."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-25-000041","json":"https://secwatch.observer/filing/0000885978-25-000041.json","markdown":"https://secwatch.observer/filing/0000885978-25-000041.md","text":"https://secwatch.observer/filing/0000885978-25-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597825000041/0000885978-25-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597825000041/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:43:36.098918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}